The MHRA is retiring the eSUSAR website in favour for Individual Case Safety Reports (ICSR) Submissions – providing users a more robust, stringent, and transparent way of expediting suspected unexpected serious adverse drug reactions (SUSARs) from Clinical Trials of Investigational … Continue reading Decommission of eSUSAR
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Related content and links
About the MHRA Inspectorate Blog
This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.
Categories
Follow us on social media
Printing Posts
You can print blog posts using the keyboard shortcuts "Control P" or "Command P".